265 filings
Page 11 of 14
S-3
57rvk
2 Dec 19
Shelf registration
5:04pm
8-K
8s8xqzpa5wd6774jup
14 Nov 19
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress
12:00am
8-K
4ned7 qhpspl6s
22 Oct 19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection
7:33am
8-K
xn8pjk
19 Aug 19
Eton Pharmaceuticals Announces Positive Results from Clinical Study Report of ET-104
7:28am
4
1pz4k88rx t6cv
13 Aug 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:04pm
4
ftlq9tac0
12 Aug 19
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:17pm
8-K
0df6fgjx3lq2s8y4hc31
6 Aug 19
Eton Announces Second Quarter Financial Results and Highlights Business Progress
4:20pm
8-K
0mbex25whc
1 Aug 19
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
8:21am
8-K
h63u svhiv
12 Jul 19
Eton Pharmaceuticals Provides Update on EM-100 Program
4:48pm
8-K
fqudj b58bl3tqhj9k
13 Jun 19
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
4:12pm
8-K
7p2tar56ti quph
12 Jun 19
Submission of Matters to a Vote of Security Holders
5:28pm
SC 13G
jw5pl06c6qr338vo81g
24 May 19
Eton Pharmaceuticals, Inc.
5:20pm
4
7xt97yh
22 May 19
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:25pm
8-K
8j79 48zn
7 May 19
Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
4:12pm
DEFA14A
2l4xu35
26 Apr 19
Additional proxy soliciting materials
4:36pm
DEF 14A
xymzwzjnggz7gxc4 51
26 Apr 19
Definitive proxy
4:34pm
S-8
uqsw6a imic3nyfvk
28 Mar 19
Registration of securities for employees
4:24pm